Fang Shi

Title: The Innovations of Fang Shi

Introduction

Fang Shi is an accomplished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of polymer science, particularly in the development of systems for targeted delivery of cytotoxic materials. Her innovative approach combines the use of interacting polymers and oligomers to enhance the efficacy of drug delivery.

Latest Patents

Fang Shi holds a patent for a "Polymer affinity system for the delivery of cytotoxic material and other." This patent describes a method that utilizes interacting polymers and oligomers to selectively target compounds to desired sites, both in vitro and in vivo. The first polymer or oligomer is bound to a targeting agent, while the second is linked to an active agent, such as a drug, metal, or radioisotope. This innovative system has the potential to improve treatment outcomes in various medical applications.

Career Highlights

Fang Shi is currently associated with Per Immune Holdings, Inc., where she continues to advance her research and development efforts. Her work focuses on creating effective delivery systems that can significantly impact therapeutic strategies. With her expertise, she has positioned herself as a key player in the field of biomedical engineering.

Collaborations

Fang Shi collaborates with Ramaswamy Subramanian, who is also a notable figure in the industry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.

Conclusion

Fang Shi's contributions to the field of polymer science and targeted drug delivery are noteworthy. Her patent and ongoing work at Per Immune Holdings, Inc. highlight her commitment to advancing medical technology. Through her innovative approaches, she is making a significant impact on the future of healthcare.